Vaccinating the world against COVID-19 is one of the most ambitious and important global health efforts of modern times. We have seen an accelerated pace of development, with vaccines arriving four times faster than prior vaccines. We have also seen an unprecedented scale of rollout globally, although it has been uneven. As the pandemic continues to evolve, some countries are now on the path to recovery and others are continuing to face challenges.
A broad range of institutions are collaborating in this historic effort to develop, distribute, and provide equitable access to COVID-19 vaccines and therapeutics. We are proud to play a small role in supporting these efforts. We have drawn upon decades of experience in global public health, led by more than 300 colleagues who bring deep expertise in public health, in-country delivery and rollout, immunology, clinical development, operations, and supply chains.
We are just at the beginning of the road to recovery, and real challenges continue to impact the lives and livelihoods of people around the world. As COVID-19 evolves, we asked some of our experts to share their perspectives on their experiences, the challenges that lie ahead, and the pandemic that is shaping us.